Citations

Clear

383 citation(s) found for "He, Rong".

Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy—Part 2: Feasibility of Margin Reduction for Fractionated Radiation Treatment with Advanced Image Guidance
Laughlin, Brady S. , Yu, Nathan Y. , Lo, Stephanie, Duan, Jingwei , Welchel, Zachary James, Tinnon, Katie, Beckett, Mason, Wong, William W. , Keole, Sameer R., Rwigema, Jean‐Claude M. , Vargas, Carlos , Welchel, Zachary, Schild, Steven E. , Duan, Jingwei , Laughlin, Brady S , Rong, Yi

Mayo Clinic

Cancers | December 22, 2022 | Volume: 15 | Issue: 1 | Pages: 40

10.3390/cancers15010040 | PMID 36612040 Get It

Purpose: Planning target volume (PTV) expansion for post-prostatectomy radiotherapy is typically ≥5 mm. Recent clinical trials have proved the feasibility of a reduced margin of 2–3 mm for treatments on MRI-linac. We aim to study the minimum PTV margin needed using iterative cone-beam CT (iCBCT) as image guidance on conventional linacs. Materials/Methods: Fourteen patients who received post-prostatectomy irradiation (8 with an endorectal balloon and 6 without a balloon) were included in this study. Treatment was delivered with volumetric modulated radiation therapy (VMAT). Fractional dose delivery was evaluated in 165 treatment fractions. The bladder, rectal wall, femoral heads, and prostate bed clinical tumor volume (CTV) were contoured and verified on daily iCBCT. PTV margins (0 mm, 2 mm, and 4 mm) were evaluated on daily iCBCT. CTV coverage and OAR dose parameters were assessed with each PTV margin. Results: CTV D100% was underdosed with a 0 mm margin in 32% of fractions in comparison with 2 mm (6%) and 4 mm (6%) PTV margin (p ≤ 0.001). CTV D95% > 95% was met in 93–94% fractions for all PTV expansions. CTV D95% > 95% was achieved in more patients with an endorectal balloon than those without: 0 mm—90/91 (99%) vs. 63/74 (85%); 2 mm—90/91 (99%) vs. 65/75 (87%); 4 mm—90/90 (100%) vs. 63/73 (86%). There was no difference in absolute median change in CTV D95% (0.32%) for 0-, 2-, and 4 mm margins. The maximum dose remained under 108% for 100% (0 mm), 97% (2 mm), and 98% (4 mm) of images. Rectal wall maximum dose remained under 108% for 100% (0 mm), 100% (2 mm), and 98% (4 mm) of images. Conclusions: With high-quality iCBCT image guidance, PTV margin accounting for inter-fractional uncertainties can be safely reduced for post-prostatectomy radiotherapy. For fractionated radiotherapy, an isotropic expansion of 2 mm and 4 mm may be considered for margin expansion with and without the endorectal balloon. Future application for margin reduction needs to be further evaluated and considered with the advent of shorter post-prostatectomy radiation courses.
Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy—Part 1: Consistent Organs at Risk Management with Advanced Image Guidance
Laughlin, Brady S. , Lo, Stephanie, Vargas, Carlos , Walt, Charles Van Der , Tinnon, Katie, Beckett, Mason, Hobbis, Dean , Wong, William W. , Keole, Sameer R., Rwigema, Jean‐Claude M. , Yu, Nathan Y. , Clouser, Edward , Van der Walt, Charles, Schild, Steven E. , Clouser, Edward Lee , Laughlin, Brady S , DeWees, T.A. , Rong, Yi

Mayo Clinic

Cancers | December 21, 2022 | Volume: 15 | Issue: 1 | Pages: 16

10.3390/cancers15010016 | PMID 36612013 Get It

Purpose: Post-operative prostate cancer patients are treated with full bladder instruction and the use of an endorectal balloon (ERB). We reassessed the efficacy of this practice based on daily image guidance and dose delivery using high-quality iterative reconstructed cone-beam CT (iCBCT). Methods: Fractional dose delivery was calculated on daily iCBCT for 314 fractions from 14 post-operative prostate patients (8 with and 6 without ERB) treated with volumetric modulated radiotherapy (VMAT). All patients were positioned using novel iCBCT during image guidance. The bladder, rectal wall, femoral heads, and prostate bed clinical tumor volume (CTV) were contoured and verified on daily iCBCT. The dose-volume parameters of the contoured organs at risk (OAR) and CTV coverage were assessed for the clinical impact of daily bladder volume variations and the use of ERB. Minimum bladder volume was studied, and a straightforward bladder instruction was explored for easy clinical adoption. Results: A “minimum bladder” contour, the overlap between the original bladder contour and a 15 mm anterior and superior expansion from prostate bed PTV, was confirmed to be effective in identifying cases that might fail a bladder constraint of V65% <60%. The average difference between the maximum and minimum bladder volumes for each patient was 277.1 mL. The daily bladder volumes varied from 62.4 to 590.7 mL and ranged from 29 to 286% of the corresponding planning bladder volume. The bladder constraint of V65% <60% was met in almost all fractions (98%). CTVs (D90%, D95%, and D98%) remained well-covered regardless of the absolute bladder volume daily variation or the presence of the endorectal balloon. Patients with an endorectal balloon showed smaller variation but a higher average maximum rectal wall dose (D0.03mL: 104.3% of the prescription) compared to patients without (103.3%). Conclusions: A “minimum bladder” contour was determined that can be easily generated and followed to ensure sufficient bladder sparing. Further analysis and validation are needed to confirm the utility of the minimal bladder contour. Accurate dose delivery can be achieved for prostate bed target coverage and OAR sparing with or without the use of ERB.
AAPM Task Group Report 306: Quality control and assurance for tomotherapy: An update to Task Group Report 148
Chen, Quan , Burmeister, Jay , Chao, Edward, Corradini, Nathan, Followill, D , Liu, An , Qi, X. Sharon , Shi, Hai-Rong, Smilowitz, Jennifer B., Rong, Yi , Li, X. Allen , Shi, Hairong, Smilowitz, Jennifer B.

Mayo Clinic

Medical Physics | December 13, 2022 | Volume: 50 | Issue: 3 | Pages: No page available

10.1002/mp.16150 | PMID 36512742 Get It

AbstractSince the publication of AAPM Task Group (TG) 148 on quality assurance (QA) for helical tomotherapy, there have been many new developments on the tomotherapy platform involving treatment delivery, on‐board imaging options, motion management, and treatment planning systems (TPSs). In response to a need for guidance on quality control (QC) and QA for these technologies, the AAPM Therapy Physics Committee commissioned TG 306 to review these changes and make recommendations related to these technology updates. The specific objectives of this TG were (1) to update, as needed, recommendations on tolerance limits, frequencies and QC/QA testing methodology in TG 148, (2) address the commissioning and necessary QA checks, as a supplement to Medical Physics Practice Guidelines (MPPG) with respect to tomotherapy TPS and (3) to provide risk‐based recommendations on the new technology implemented clinically and treatment delivery workflow. Detailed recommendations on QA tests and their tolerance levels are provided for dynamic jaws, binary multileaf collimators, and Synchrony motion management. A subset of TPS commissioning and QA checks in MPPG 5.a. applicable to tomotherapy are recommended. In addition, failure mode and effects analysis has been conducted among TG members to obtain multi‐institutional analysis on tomotherapy‐related failure modes and their effect ranking.
JSENSE‐Pro: Joint sensitivity estimation and image reconstruction in parallel imaging using pre‐learned subspaces of coil sensitivity functions
Tang, Lihong , Zhao, Yibo , Li, Yudu , Guo, Rong , Cai, Bingyang, Wang, Jia , Li, Yao , Liang, Zhi‐Pei , Peng, Xi , Luo, Jie , Yang, H. J. , Peng, Xi

Mayo Clinic

Magnetic Resonance in Medicine | December 8, 2022 | Volume: 89 | Issue: 4 | Pages: 1531-1542

10.1002/mrm.29548 | PMID 36480000 Get It

PurposeTo improve calibrationless parallel imaging using pre‐learned subspaces of coil sensitivity functions.Theory and MethodsA subspace‐based joint sensitivity estimation and image reconstruction method was developed for improved parallel imaging with no calibration data. Specifically, we proposed to use a probabilistic subspace model to capture prior information of the coil sensitivity functions from previous scans acquired using the same receiver system. Both the subspace basis and coefficient distributions were learned from a small set of training data. The learned subspace model was then incorporated into the regularized reconstruction formalism that includes a sparsity prior. The nonlinear optimization problem was solved using alternating minimization algorithm. Public fastMRI brain dataset was retrospectively undersampled by different schemes for performance evaluation of the proposed method.ResultsWith no calibration data, the proposed method consistently produced the most accurate coil sensitivity estimation and highest quality image reconstructions at all acceleration factors tested in comparison with state‐of‐the‐art methods including JSENSE, DeepSENSE, P‐LORAKS, and Sparse BLIP. Our results are comparable to or even better than those from SparseSENSE, which used calibration data for sensitivity estimation. The work also demonstrated that the probabilistic subspace model learned from T2w data can be generalized to aiding the reconstruction of FLAIR data acquired from the same receiver system.ConclusionA subspace‐based method named JSENSE‐Pro has been proposed for accelerated parallel imaging without the acquisition of companion calibration data. The method is expected to further enhance the practical utility of parallel imaging, especially in applications where calibration data acquisition is not desirable or limited.
Characteristics and Outcomes of Patients with BCOR Mutated Myeloid Neoplasms
Barua, Amit , Yıkılmaz, Aysun Şentürk , He, Rong , Viswanatha, David S., Katamesh, Bahga , Mangaonkar, Abhishek A. , Gangat, Naseema , Patnaik, Mrinal M. , Litzow, Mark R. , Begna, Kebede H. , Tefferi, Ayalew , Al‐Kali, Aref , Baranwal, Anmol , Shah, Meera , Badar, Talha , Hogan, William J. , Alkhateeb, Hassan B.

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3235-3236

10.1182/blood-2022-169319 Get It

Treatment Patterns and Outcomes of Patients with Chronic Lymphocytic Leukemia with TP53 Mutations
He, Rong , Hampel, Paul J. , Call, Timothy G. , Koehler, Amber B. , Behnken, Amy, Leis, José F., Viswanatha, David S., Dyke, Daniel L. Van , Hwang, Steven R. , Wang, Yucai , Rabe, Kari G. , Kenderian, Saad S. , Muchtar, Eli , Kay, Neil E. , Braggio, Esteban , Shi, Min , Slager, Susan L. , Parikh, Sameer A. , Ding, Wei

Mayo Clinic

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12390-12392

10.1182/blood-2022-165508 Get It

Differential Impact on Survival in Myeloid Neoplasm Patients with U2AF1 Mutations
Vanegas, Yenny Moreno , Nanaa, Ahmad , Al‐Kali, Aref , He, Rong , Patnaik, Mrinal M. , Gangat, Naseema , Litzow, Mark R. , Tefferi, Ayalew , Alkhateeb, Hassan B. , Shah, Meera , Badar, Talha

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9602-9603

10.1182/blood-2022-167405 Get It